These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22467315)

  • 1. Non-endothelial cell endothelin-B receptors limit neointima formation following vascular injury.
    Kirkby NS; Duthie KM; Miller E; Kotelevtsev YV; Bagnall AJ; Webb DJ; Hadoke PW
    Cardiovasc Res; 2012 Jul; 95(1):19-28. PubMed ID: 22467315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective endothelin A receptor antagonism with sitaxentan reduces neointimal lesion size in a mouse model of intraluminal injury.
    Duthie KM; Hadoke PW; Kirkby NS; Miller E; Ivy JR; McShane JF; Lim WG; Webb DJ
    Br J Pharmacol; 2015 Jun; 172(11):2827-37. PubMed ID: 25598351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smooth Muscle Endothelin B Receptors Regulate Blood Pressure but Not Vascular Function or Neointimal Remodeling.
    Miller E; Czopek A; Duthie KM; Kirkby NS; van de Putte EE; Christen S; Kimmitt RA; Moorhouse R; Castellan RF; Kotelevtsev YV; Kuc RE; Davenport AP; Dhaun N; Webb DJ; Hadoke PW
    Hypertension; 2017 Feb; 69(2):275-285. PubMed ID: 28028193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin a receptor blockade and endothelin B receptor blockade improve hypokalemic nephropathy by different mechanisms.
    Suga S; Yasui N; Yoshihara F; Horio T; Kawano Y; Kangawa K; Johnson RJ
    J Am Soc Nephrol; 2003 Feb; 14(2):397-406. PubMed ID: 12538740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of endothelin receptors on basal and endothelin-1-stimulated lung myofibroblast proliferation.
    Préfontaine A; Calderone A; Dupuis J
    Can J Physiol Pharmacol; 2008 Jun; 86(6):337-42. PubMed ID: 18516096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonselective ETA/ETB-receptor blockade increases systemic blood pressure of Bio 14.6 cardiomyopathic hamsters.
    Honoré JC; Carrier E; Fecteau MH; Tirapelli CR; Bkaily G; D'Orleans-Juste P
    Can J Physiol Pharmacol; 2008 Jun; 86(6):394-401. PubMed ID: 18516103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective endothelin ETA and dual ET(A)/ET(B) receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease.
    Rafnsson A; Shemyakin A; Pernow J
    Life Sci; 2014 Nov; 118(2):435-9. PubMed ID: 24607773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cell-specific ETB receptor knockout: autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1.
    Kelland NF; Kuc RE; McLean DL; Azfer A; Bagnall AJ; Gray GA; Gulliver-Sloan FH; Maguire JJ; Davenport AP; Kotelevtsev YV; Webb DJ
    Can J Physiol Pharmacol; 2010 Jun; 88(6):644-51. PubMed ID: 20628430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular Effects of Endothelin Receptor Antagonists Depends on Their Selectivity for ETA Versus ETB Receptors and on the Functionality of Endothelial ETB Receptors.
    Iglarz M; Steiner P; Wanner D; Rey M; Hess P; Clozel M
    J Cardiovasc Pharmacol; 2015 Oct; 66(4):332-7. PubMed ID: 25992919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADP-ribosyl cyclase and ryanodine receptors mediate endothelin ETA and ETB receptor-induced renal vasoconstriction in vivo.
    Thai TL; Arendshorst WJ
    Am J Physiol Renal Physiol; 2008 Aug; 295(2):F360-8. PubMed ID: 18524860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endothelin-1 and its receptors, ET
    Mikhail M; Vachon PH; D'Orléans-Juste P; Jacques D; Bkaily G
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1298-1305. PubMed ID: 28732172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model.
    Battistini B; Verreault M; Ayach B; Blouin A; Cernacek P; Jeng AY; Wessale J; Opgenorth T; Tsang J
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S386-9. PubMed ID: 15838327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma- and cerebrospinal fluid-immunoreactive endothelin-1: effects of nonpeptide endothelin receptor antagonists with diverse affinity profiles for endothelin-A and endothelin-B receptors.
    Willette RN; Sauermelch CF; Storer BL; Guiney S; Luengo JI; Xiang JN; Elliott JD; Ohlstein EH
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S149-57. PubMed ID: 9595425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of endothelin ETA receptors masks the constrictor role of endothelin ETB receptors in rat isolated small mesenteric arteries.
    Mickley EJ; Gray GA; Webb DJ
    Br J Pharmacol; 1997 Apr; 120(7):1376-82. PubMed ID: 9105715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of either the ETA or the ETB receptors is involved in the development of electrographic seizures following intrahippocampal infusion of the endothelin-1 in immature rats.
    Tsenov G; Vondrakova K; Otahal J; Burchfiel J; Kubova H
    Exp Neurol; 2015 Mar; 265():40-7. PubMed ID: 25542981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endothelin system in pulmonary arterial hypertension.
    Galié N; Manes A; Branzi A
    Cardiovasc Res; 2004 Feb; 61(2):227-37. PubMed ID: 14736539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin ET
    Vercauteren M; Trensz F; Pasquali A; Cattaneo C; Strasser DS; Hess P; Iglarz M; Clozel M
    J Pharmacol Exp Ther; 2017 May; 361(2):322-333. PubMed ID: 28223322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive endothelin-1 gene activation initiates chronic/end-stage renal disease following experimental ischemic/reperfusion injury.
    Zager RA; Johnson AC; Andress D; Becker K
    Kidney Int; 2013 Oct; 84(4):703-12. PubMed ID: 23698233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin receptor subtypes in the pathogenesis of angioplasty-induced neointima formation in the rat: a comparison of selective ETA receptor antagonism and dual ETA/ETB receptor antagonism using BQ-123 and SB 209670.
    Douglas SA; Vickery-Clark LM; Louden C; Elliott JD; Ohlstein EH
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S186-9. PubMed ID: 8587358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes.
    Harris AK; Elgebaly MM; Li W; Sachidanandam K; Ergul A
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1213-9. PubMed ID: 18287215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.